NASDAQ: GLYC       Glycomimetics Inc
Last Price Today's Change   Day's Range   Trading Volume
6.63   +0.37 (5.91%)  6.283 - 6.69  184,449


Avg Volume (4 weeks):198,245
4 Weeks Range:4.44 - 6.69
4 Weeks Price Volatility (%):
52 Weeks Range:2.64 - 13.56
52 Weeks Price Volatility (%):
Average Price Target: 14.00
Price Target Upside/Downside: +7.37


No recent Headlines for this stock.

Business Background

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

  Be the first to like this.


3013  2511  433  3020 

Top 10 Active Counters
 FCEL 0.909+0.099 
 CHK 0.696-0.005 
 AMD 38.409+0.889 
 CSCO 44.685-3.775 
 AABA 19.630.00 
 CPE 4.24-0.22 
 SNNA 0.293+0.133 
 NIO 1.735-0.165 
 NOK 3.355-0.115 
 AMRN 21.490.00 
Partners & Brokers